3,475 results on '"Filippatos, Gerasimos"'
Search Results
2. Clinical trial design and interpretation
3. Acute heart failure: diagnostic and prognostic assessment
4. Dietary sodium and fluid intake in heart failure. A clinical consensus statement of the Heart Failure Association of the ESC
5. Implementation Approaches in Heart Failure With Mildly Reduced and Preserved Ejection Fraction
6. Body mass index and cardiorenal outcomes in the EMPEROR‐Preserved trial: Principal findings and meta‐analysis with the DELIVER trial
7. Impact of empagliflozin on insulin needs in patients with heart failure and diabetes: An EMPEROR‐Pooled analysis
8. Impact of Rapid Up-Titration of Guideline-Directed Medical Therapies on Quality of Life: Insights From the STRONG-HF Trial
9. Blood pressure and intensive treatment up‐titration after acute heart failure hospitalization: Insights from the STRONG‐HF trial
10. Epidemiology and risk factors for hyperkalaemia in heart failure
11. Empagliflozin and risk of lower respiratory tract infection in heart failure with mildly reduced and preserved ejection fraction: An EMPEROR‐Preserved analysis
12. Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists
13. Urinary Marker Profiles in Heart Failure with Reduced Versus Preserved Ejection Fraction
14. The Han:SPRD Rat: A Preclinical Model of Polycystic Kidney Disease
15. Early changes in estimated glomerular filtration rate post‐initiation of empagliflozin in EMPEROR‐Preserved
16. The effect of sodium–glucose cotransporter 2 inhibitors on left cardiac remodelling in heart failure with reduced ejection fraction: Systematic review and meta‐analysis
17. Epidemiology, pathophysiology, diagnosis and management of chronic right‐sided heart failure and tricuspid regurgitation. A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC
18. Performance of Different Risk Scores for the Detection of Atrial Fibrillation Among Patients With Cryptogenic Stroke
19. Autonomic Regulation Therapy To Improve Symptoms And Clinical Outcomes In Patients With Heart Failure And Reduced Ejection Fraction (ANTHEM-HFrEF) Pivotal Study Results
20. Safety Indicators In Patients Receiving High-intensity Care After Acute Heart Failure Admission: The STRONG-HF Trial
21. Variation Of Prespecified Subgroups In Large-Scale HF Outcome Trials
22. Optimization of Evidence-Based Heart Failure Medications After an Acute Heart Failure Admission
23. European Society of Cardiology Core Curriculum for Cardio‐Oncology
24. CARDIOCARE platform: A beyond the state of the art approach for the management of elderly multimorbid patients with breast cancer therapy induced cardiac toxicity*
25. Differential biomarker expression in heart failure patients with and without mitral regurgitation: Insights from BIOSTAT-CHF
26. Standardized Definitions for Evaluation of Acute Decompensated Heart Failure Therapies
27. Multimorbidity in patients with acute heart failure across world regions and country income levels (REPORT-HF): a prospective, multicentre, global cohort study
28. Implications of worsening renal function before hospitalization for acute heart failure
29. Sacubitril/valsartan compared to ramipril in high‐risk post‐myocardial infarction patients stratified according to use of mineralocorticoid receptor antagonists: insight from the PARADISE MI trial
30. Cell Therapy Improves Quality-of-Life in Heart Failure: Outcomes From a Phase III Clinical Trial
31. Plain language summary of the EMPEROR-Preserved study looking at the effect of empagliflozin in patients with heart failure with preserved ejection fraction, with and without diabetes
32. GDF‐15 and the Effect of Empagliflozin in Heart Failure: Findings from the EMPEROR Program
33. Incidence, risk assessment and prevention of sudden cardiac death in cardiomyopathies
34. Abstract 15115: Efficacy and Safety of miR-132 Inhibitor CDR132L in Patients With Reduced Left Ventricular Ejection Fraction After Myocardial Infarction: Rationale for and Design of the HF-REVERT Trial
35. The ESC Textbook of Heart Failure
36. Repurposing the β3-Adrenergic Receptor Agonist Mirabegron in Patients With Structural Cardiac Disease
37. LEFT VENTRICULAR EJECTION FRACTION DIGIT BIAS AND RECLASSIFICATION OF HEART FAILURE WITH MILDLY REDUCED VS. REDUCED EJECTION FRACTION BASED ON THE 2021 DEFINITION AND CLASSIFICATION OF HEART FAILURE
38. Cardiorenal multimorbidity in hospitalized cardiology patients: The Hellenic Cardiorenal Morbidity Snapshot (HECMOS) study
39. Non‐cardiac comorbidities and intensive up‐titration of oral treatment in patients recently hospitalized for heart failure: Insights from the STRONG‐HF trial
40. Vascular Disease Burden, Outcomes and Benefits with Empagliflozin in Heart Failure: Insights From the EMPEROR-Reduced Trial
41. Safety Indicators in Patients Receiving High-intensity Care After Hospital Admission for Acute Heart Failure: The STRONG-HF Trial
42. Blinded Withdrawal of Long-Term Randomized Treatment With Empagliflozin or Placebo in Patients With Heart Failure
43. State‐of‐the‐art document on optimal contemporary management of cardiomyopathies
44. Associations between baseline heart rate and blood pressure and time to events in heart failure with reduced ejection fraction patients: Data from the QUALIFY international registry
45. Decongestion strategies in patients presenting with acutely decompensated heart failure: A worldwide survey among physicians
46. Back Cover
47. Adaptive versus conventional cardiac resynchronisation therapy in patients with heart failure (AdaptResponse): a global, prospective, randomised controlled trial
48. Global Variations According to Sex in Patients Hospitalized for Heart Failure in the REPORT-HF Registry
49. Efficacy and Safety of Empagliflozin According to Background Diuretic Use in Heart Failure With Reduced Ejection Fraction
50. Intravenous ferric carboxymaltose for iron repletion following acute heart failure in patients with and without diabetes: a subgroup analysis of the randomized AFFIRM-AHF trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.